Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events understanding critical element search alzheimer’s disease treatments
… Consortium ( MDIC ) that will work with Parkinson’s patients to determine the benefit and risk tradeoffs they … allow smaller trials, and enable groups representing rare disease states or smaller patient populations to participate … development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, …
… ophthalmology, infectious diseases, cardiovascular disease, endocrinology, urology, gynecology, oncology, … regular basis in order to remain up-to-date on the latest news regarding AMCP dossiers. …
… areas, including, but not limited, to aesthetics, Alzheimer's disease, autoimmune disease, dermatology, eye conditions, …
… Melanoma Myelofibrosis Neuroendocrine tumors Non-Hodgkin’s lymphoma Renal cell carcinoma Osteosarcoma Ovarian cancer … studies Economic burden of illness studies Epidemiology of disease Exploratory analyses of clinical trial data Global …
Patricia Sacco Surveys and Observational Studies Respiratory Psychiatry Diabetes & Endocrine Disorders Dermatology CNS/Neurology Cardiovascular Autoimmune Diseases Telecommuter - USA MPH, School of Public Health University of Medicine & Dentistry of New …
… Dana DiBenedetti Patient-Centered Outcomes Assessment Women's Health Psychiatry Men's Health Hematology Diabetes & … schizophrenia, attention-deficit/hyperactivity disorder, Alzheimer’s disease, bipolar disorder, borderline personality disorder, …
… other acromegaly PRO measures. The quality of the ASD’s measurement in the context of other PRO measures was …
… in 2010 with a degree in neuroscience. He holds a master’s degree in science in Health Economics and Decision … developing cost-effectiveness and budget-impact models for Alzheimer’s disease. During his time at RTI-HS, Mr. Brockbank has …
AMCP 2022 Share on: Tuesday, March 29 - Friday, April 1, 2022 Conference Website Research coauthored by RTI Health Solutions researcher Bradley Layton will be presented at AMCP 2022. Immunoglobulin initiation among patients with primary immunodeficiency …
… in brain volume loss with teriflunomide versus other disease-modifying therapies in relapsing multiple sclerosis: …